![](https://library.celltelligence.com/wp-content/uploads/2021/10/T-Cure_Atlas-Antibodies_Partnership.png)
$0
T-Cure Partners With Atlas to Develop a KK-LC-1 Diagnostic Test
On Tuesday, October 5, T-Cure announced (press release) a collaborative agreement with Atlas Antibodies for the development, manufacture, and supply of CT83 (KK-LC-1-directed monoclonal antibody). Of note, CT83 will be used for the development of a diagnostic test to identify KK-LC-1-expressing tumors. Below, Celltelligence provides insights on how the use of a companion diagnostic test could improve clinical outcomes, while discussing T-Cure’s novel TCR-T pipeline.